MECOM (Q03112) variants and mutations
MECOM (also known as Q03112) is a human protein-coding gene encoding a histone-lysine N-methyltransferase protein. Its EVI1-containing transcriptional programs regulate hematopoietic stem-cell self-renewal and differentiation. Rearrangement or overexpression is a potent adverse-risk driver in myeloid malignancies, while germline variants can cause congenital bone-marrow failure and developmental syndromes. This analysis covers 1,885 MECOM variants and mutations. Of these, 52% have computational variant effect predictions. Disease context includes Radio-ulnar synostosis - amegakaryocytic thrombocytopenia, radioulnar synostosis with amegakaryocytic thrombocytopenia 2, and MECOM-associated syndrome. Example MECOM variants include R2K, S3A, and S3F.
Variant analysis overview
- Gene: MECOM
- Protein: Q03112
- UniProt accession: Q03112
- Organism: Homo sapiens
- Variants analyzed: 1885
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 1,629 unspecified-consequence records; 74 synonymous variants; 163 missense variants; 9 frameshift variants; 6 stop-gained variants; 2 in-frame deletions; 2 splice-region variants
- Prediction scores: 985 variants have prediction scores (52% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Radio-ulnar synostosis - amegakaryocytic thrombocytopenia, radioulnar synostosis with amegakaryocytic thrombocytopenia 2, MECOM-associated syndrome, congenital radioulnar synostosis, hypertensive disorder, glaucoma, preeclampsia, open-angle glaucoma, asthma, prostate carcinoma, essential hypertension, gout.
Protein structure and variant hotspots
- Protein features: 1 domains; 5 post-translational modification sites.
- Structural context: 132 variants have structural context.
- PTM context: 7 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable MECOM variants
Examples include R2K, S3A, S3F, K4I, K4N, G5V, R6K, A7E. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- R2K (p.Arg2Lys), Ensembl rs2110156907, CADD 23.00, PolyPhen-2 0.16
- S3A (p.Ser3Ala), Ensembl rs2110156893
- S3F (p.Ser3Phe), ExAC rs775492251, TOPMed rs775492251, gnomAD rs775492251, CADD 25.00, PolyPhen-2 0.65
- K4I (p.Lys4Ile), cosmic curated COSV10974
- K4N (p.Lys4Asn), TOPMed rs1013793867, gnomAD rs1013793867, CADD 24.00, PolyPhen-2 0.01
- G5V (p.Gly5Val), TOPMed rs960179876, gnomAD rs960179876, CADD 23.20, PolyPhen-2 0.26
- R6K (p.Arg6Lys), rs1032716797, Ensembl rs1032716797, AlphaMissense 0.32, MetaLR 0.05, Variant assessed as somatic; moderate impact.
- A7E (p.Ala7Glu), gnomAD rs1486416790
- A7T (p.Ala7Thr), cosmic curated COSV10152
- L10R (p.Leu10Arg), TOPMed rs1776580814
- A11V (p.Ala11Val), ExAC rs767578342, TOPMed rs767578342, gnomAD rs767578342, CADD 24.50, PolyPhen-2 0.00
- T12K (p.Thr12Lys), ExAC rs759668706, gnomAD rs759668706, CADD 21.40, PolyPhen-2 0.00, Likely benign, Radioulnar synostosis with amegakaryocytic thrombocytopenia 2
- N13D (p.Asn13Asp), ExAC rs774899267, gnomAD rs774899267, CADD 23.50, PolyPhen-2 0.02
- N13K (p.Asn13Lys), cosmic curated COSV10471
- N13S (p.Asn13Ser), TOPMed rs1014218346
- N13T (p.Asn13Thr), cosmic curated COSV72110
- N14D (p.Asn14Asp), TOPMed rs1370395898, gnomAD rs1370395898, CADD 14.40, PolyPhen-2 0.00
- E15G (p.Glu15Gly), gnomAD rs1302165695, CADD 22.70, PolyPhen-2 0.68
- E15K (p.Glu15Lys), ExAC rs770279647, TOPMed rs770279647, gnomAD rs770279647, CADD 20.70, PolyPhen-2 0.48
- C16G (p.Cys16Gly), ExAC rs762327252, TOPMed rs762327252, gnomAD rs762327252, CADD 19.10, PolyPhen-2 0.45
- C16R (p.Cys16Arg), ExAC rs762327252, TOPMed rs762327252, gnomAD rs762327252, CADD 22.80, PolyPhen-2 0.73
- C16S (p.Cys16Ser), ExAC rs776402461, TOPMed rs776402461, gnomAD rs776402461, CADD 14.60, PolyPhen-2 0.53
- C16Y (p.Cys16Tyr), ExAC rs776402461, TOPMed rs776402461, gnomAD rs776402461, CADD 18.10, PolyPhen-2 0.41
- V17E (p.Val17Glu), TOPMed rs1437924277, CADD 10.20, PolyPhen-2 0.03
- V17I (p.Val17Ile), gnomAD rs1372371559, CADD 7.78, PolyPhen-2 0.00
- Y18F (p.Tyr18Phe), TOPMed rs1319048281, gnomAD rs1319048281, CADD 16.70, PolyPhen-2 0.20
- Y18H (p.Tyr18His), ExAC rs768464136, TOPMed rs768464136, gnomAD rs768464136, CADD 22.80, PolyPhen-2 0.66
- Y21C (p.Tyr21Cys), cosmic curated COSV99072, ExAC rs771991577, TOPMed rs771991577, gnomAD rs771991577, CADD 21.10, PolyPhen-2 0.30, Uncertain significance, not provided; Inborn genetic diseases
- Y21H (p.Tyr21His), ExAC rs779455664, gnomAD rs779455664, CADD 18.50, PolyPhen-2 0.09
- Y21N (p.Tyr21Asn), ExAC rs779455664, gnomAD rs779455664, CADD 18.10, PolyPhen-2 0.00
- Y21S (p.Tyr21Ser), ExAC rs771991577, TOPMed rs771991577, gnomAD rs771991577, CADD 16.10, PolyPhen-2 0.00
- P22A (p.Pro22Ala), TOPMed rs1229196026, gnomAD rs1229196026
- P22L (p.Pro22Leu), TOPMed rs1453120808, gnomAD rs1453120808, CADD 15.90, PolyPhen-2 0.00, Likely benign, not provided
- P22R (p.Pro22Arg), TOPMed rs1453120808, gnomAD rs1453120808
- P22S (p.Pro22Ser), cosmic curated COSV72110
- P22T (p.Pro22Thr), cosmic curated COSV72111, TOPMed rs1229196026, gnomAD rs1229196026, CADD 8.75, PolyPhen-2 0.01
- E23G (p.Glu23Gly), Ensembl rs2108278083
- E23K (p.Glu23Lys), NCI-TCGA Cosmic COSV7211, cosmic curated COSV72111, Variant assessed as somatic; moderate impact.
- I24L (p.Ile24Leu), Ensembl rs2108278061
- I24T (p.Ile24Thr), cosmic curated COSV10753
- P25L (p.Pro25Leu), TOPMed rs1271972945
- P25S (p.Pro25Ser), cosmic curated COSV72111, gnomAD rs888091596, CADD 15.20, PolyPhen-2 0.00
- E27* (p.Glu27Ter), rs757020094, ClinGen CA355192249, ClinVar RCV001727275, ExAC rs757020094, AlphaMissense 0.12, MetaLR 0.05, Uncertain significance
- E27G (p.Glu27Gly), Ensembl rs2108277979
- E27K (p.Glu27Lys), rs757020094, NCI-TCGA Cosmic COSV1015, cosmic curated COSV10152, ExAC rs757020094, AlphaMissense 0.12, MetaLR 0.05, Uncertain significance
- M29I (p.Met29Ile), TOPMed rs1732376260, CADD 13.60, PolyPhen-2 0.00
- P30S (p.Pro30Ser), TOPMed rs1732375934, CADD 10.50, PolyPhen-2 0.00
- P30T (p.Pro30Thr), TOPMed rs1732375934, CADD 11.30, PolyPhen-2 0.06
- D31G (p.Asp31Gly), TOPMed rs1191468270, gnomAD rs1191468270, CADD 15.20, PolyPhen-2 0.11
- D31H (p.Asp31His), cosmic curated COSV72110, TOPMed rs1329169678, gnomAD rs1329169678, CADD 18.20
- A32S (p.Ala32Ser), NCI-TCGA Cosmic COSV1015, cosmic curated COSV10152, Variant assessed as somatic; moderate impact.
- D33A (p.Asp33Ala), TOPMed rs1732374379, gnomAD rs1732374379, CADD 19.30
- D33N (p.Asp33Asn), ExAC rs753669729, gnomAD rs753669729, CADD 22.40, PolyPhen-2 0.22
- G34E (p.Gly34Glu), cosmic curated COSV72109
- V35G (p.Val35Gly), gnomAD rs1204240292
- V35I (p.Val35Ile), TOPMed rs1261966114, gnomAD rs1261966114, CADD 8.54, PolyPhen-2 0.00
- A36G (p.Ala36Gly), 1000Genomes rs537331052, ExAC rs537331052, gnomAD rs537331052, CADD 5.47, PolyPhen-2 0.00
- A36S (p.Ala36Ser), ExAC rs781351398, TOPMed rs781351398, gnomAD rs781351398, CADD 9.40, PolyPhen-2 0.01
- A36T (p.Ala36Thr), ExAC rs781351398, TOPMed rs781351398, gnomAD rs781351398, CADD 13.50, PolyPhen-2 0.00
- S37G (p.Ser37Gly), gnomAD rs1732372740, CADD 1.46, PolyPhen-2 0.00
- T38I (p.Thr38Ile), gnomAD rs1349174102, CADD 5.82, PolyPhen-2 0.01
- T38N (p.Thr38Asn), gnomAD rs1349174102, CADD 3.38, PolyPhen-2 0.06
- T38P (p.Thr38Pro), ExAC rs751599149, TOPMed rs751599149, gnomAD rs751599149, CADD 4.41, PolyPhen-2 0.00
- P39A (p.Pro39Ala), ESP rs371288694, ExAC rs371288694, TOPMed rs371288694, gnomAD rs371288694
- P39L (p.Pro39Leu), cosmic curated COSV10660, Ensembl rs1258616964
- P39S (p.Pro39Ser), cosmic curated COSV72110
- P39T (p.Pro39Thr), ESP rs371288694, ExAC rs371288694, TOPMed rs371288694, gnomAD rs371288694, CADD 2.08, PolyPhen-2 0.01
- S40C (p.Ser40Cys), ExAC rs763161743, TOPMed rs763161743, gnomAD rs763161743, CADD 18.60, PolyPhen-2 0.00
- S40F (p.Ser40Phe), cosmic curated COSV10753
- S40P (p.Ser40Pro), rs1439121848, NCI-TCGA Cosmic COSV1015, cosmic curated COSV10152, gnomAD rs1439121848, AlphaMissense 0.08, MetaLR 0.18, Variant assessed as somatic; moderate impact.
- L41R (p.Leu41Arg), cosmic curated COSV72110
- L41V (p.Leu41Val), TOPMed rs1381796367, gnomAD rs1381796367, CADD 10.10, PolyPhen-2 0.00
- N42D (p.Asn42Asp), ExAC rs765894702, TOPMed rs765894702, gnomAD rs765894702, CADD 9.70, PolyPhen-2 0.01
- N42S (p.Asn42Ser), cosmic curated COSV72109, CADD 0.06, PolyPhen-2 0.00
- I43F (p.Ile43Phe), gnomAD rs893762079, CADD 1.35, PolyPhen-2 0.03
- I43N (p.Ile43Asn), TOPMed rs1435450452, gnomAD rs1435450452, CADD 16.70, PolyPhen-2 0.24
- Q44P (p.Gln44Pro), ExAC rs762237413, TOPMed rs762237413, gnomAD rs762237413, CADD 15.30, PolyPhen-2 0.00
- E45A (p.Glu45Ala), TOPMed rs1171738129, gnomAD rs1171738129, CADD 17.50, PolyPhen-2 0.12
- E45V (p.Glu45Val), TOPMed rs1171738129, gnomAD rs1171738129, CADD 20.30
- P46L (p.Pro46Leu), ESP rs376185183, TOPMed rs376185183, gnomAD rs376185183, CADD 21.70, PolyPhen-2 0.00
- C47F (p.Cys47Phe), ExAC rs768309554, TOPMed rs768309554, gnomAD rs768309554, CADD 15.40, PolyPhen-2 0.05, Uncertain significance, MECOM-related disorder
- C47W (p.Cys47Trp), ESP rs373555129, TOPMed rs373555129, gnomAD rs373555129, CADD 19.40, PolyPhen-2 0.21
- C47Y (p.Cys47Tyr), ExAC rs768309554, TOPMed rs768309554, gnomAD rs768309554, CADD 14.90, PolyPhen-2 0.08, Uncertain significance
- S48F (p.Ser48Phe), cosmic curated COSV10536, TOPMed rs1380961098, gnomAD rs1380961098, CADD 22.50, PolyPhen-2 0.01
- S48P (p.Ser48Pro), rs760262585, ClinGen CA2696717, ClinVar RCV003887298, ExAC rs760262585, CADD 23.60, PolyPhen-2 0.69, Likely benign, not provided
- S48Y (p.Ser48Tyr), NCI-TCGA Cosmic COSV1015, cosmic curated COSV10152, Variant assessed as somatic; moderate impact.
- P49S (p.Pro49Ser), TOPMed rs1732363714, CADD 22.10, PolyPhen-2 0.49
- A50T (p.Ala50Thr), cosmic curated COSV72111
- T51I (p.Thr51Ile), ExAC rs745429497, gnomAD rs745429497
- S52F (p.Ser52Phe), cosmic curated COSV10536, ExAC rs778787527, TOPMed rs778787527, gnomAD rs778787527
- S52P (p.Ser52Pro), cosmic curated COSV72111, Uncertain significance, Inborn genetic diseases; not provided
- S52Y (p.Ser52Tyr), ExAC rs778787527, TOPMed rs778787527, gnomAD rs778787527
- S53G (p.Ser53Gly), Ensembl rs1732361252, CADD 17.10
- S53N (p.Ser53Asn), ExAC rs770881104, TOPMed rs770881104, gnomAD rs770881104, CADD 14.70, PolyPhen-2 0.00
- S53T (p.Ser53Thr), ExAC rs770881104, TOPMed rs770881104, gnomAD rs770881104, CADD 14.60, PolyPhen-2 0.02
- F56C (p.Phe56Cys), Ensembl rs1577927602
- F56L (p.Phe56Leu), ExAC rs749033118, gnomAD rs749033118, CADD 17.60, PolyPhen-2 0.00
- P58A (p.Pro58Ala), ExAC rs777557842, TOPMed rs777557842, gnomAD rs777557842, CADD 22.10, PolyPhen-2 0.18
- P58L (p.Pro58Leu), TOPMed rs1171762526
- K59M (p.Lys59Met), gnomAD rs1315052718, CADD 24.60, PolyPhen-2 0.79
- E60A (p.Glu60Ala), ESP rs369826375, ExAC rs369826375, TOPMed rs369826375, gnomAD rs369826375, CADD 23.70, PolyPhen-2 0.05
- E60K (p.Glu60Lys), cosmic curated COSV10471
- G61A (p.Gly61Ala), ExAC rs780382585, TOPMed rs780382585, gnomAD rs780382585, CADD 22.40, PolyPhen-2 0.08
- G61C (p.Gly61Cys), TOPMed rs1310987523, gnomAD rs1310987523, CADD 24.00, PolyPhen-2 0.74
- G61S (p.Gly61Ser), cosmic curated COSV10152, TOPMed rs1310987523, gnomAD rs1310987523, CADD 22.40
- G61V (p.Gly61Val), ExAC rs780382585, TOPMed rs780382585, gnomAD rs780382585, CADD 22.80, PolyPhen-2 0.53
- S62C (p.Ser62Cys), cosmic curated COSV72110
- S62F (p.Ser62Phe), Ensembl rs867856609, CADD 23.70, PolyPhen-2 0.01
- P63L (p.Pro63Leu), cosmic curated COSV10753, 1000Genomes rs369363004, ESP rs369363004, ExAC rs369363004, CADD 27.20, PolyPhen-2 1.00, Likely benign
- P63R (p.Pro63Arg), rs369363004, ClinGen CA2696704, ClinVar RCV003907063, ClinVar RCV005416749, CADD 26.30, PolyPhen-2 1.00, Uncertain significance, not provided
- P63S (p.Pro63Ser), cosmic curated COSV10753, CADD 23.80, PolyPhen-2 1.00
- K65N (p.Lys65Asn), gnomAD rs1188279586, CADD 20.80, PolyPhen-2 0.08
- K65R (p.Lys65Arg), TOPMed rs1419537805, gnomAD rs1419537805, CADD 22.90, PolyPhen-2 0.00
- A66G (p.Ala66Gly), TOPMed rs929448789, gnomAD rs929448789, CADD 22.80, PolyPhen-2 0.01
- A66T (p.Ala66Thr), TOPMed rs1474588403, gnomAD rs1474588403, CADD 23.50, PolyPhen-2 0.13
- A66V (p.Ala66Val), cosmic curated COSV10974, TOPMed rs929448789, gnomAD rs929448789, CADD 22.80, PolyPhen-2 0.01
- P67L (p.Pro67Leu), cosmic curated COSV10594
- P67R (p.Pro67Arg), ExAC rs764373815, gnomAD rs764373815, CADD 23.10, PolyPhen-2 0.61
- P67S (p.Pro67Ser), 1000Genomes rs565742596, ExAC rs565742596, gnomAD rs565742596, CADD 21.80, PolyPhen-2 0.19
- I68N (p.Ile68Asn), TOPMed rs1732353367, CADD 24.30, PolyPhen-2 0.36
- I68V (p.Ile68Val), cosmic curated COSV72110
- Y69C (p.Tyr69Cys), TOPMed rs1473639483, CADD 24.50, PolyPhen-2 0.95
- I70V (p.Ile70Val), TOPMed rs1274356562, gnomAD rs1274356562, CADD 22.90, PolyPhen-2 0.41
- P71L (p.Pro71Leu), TOPMed rs1195556096, gnomAD rs1195556096, CADD 22.80, PolyPhen-2 0.46
- D73G (p.Asp73Gly), TOPMed rs1295334491, gnomAD rs1295334491
- D73N (p.Asp73Asn), rs761171278, NCI-TCGA Cosmic COSV7211, cosmic curated COSV72110, ExAC rs761171278, CADD 25.10, PolyPhen-2 1.00, Variant assessed as somatic; moderate impact.
- D73V (p.Asp73Val), TOPMed rs1295334491, gnomAD rs1295334491, CADD 26.90, PolyPhen-2 1.00
- I74N (p.Ile74Asn), TOPMed rs1732350213
- P75T (p.Pro75Thr), NCI-TCGA Cosmic COSV7210, cosmic curated COSV72109, Variant assessed as somatic; moderate impact.
- I76M (p.Ile76Met), TOPMed rs1560202347, CADD 23.00, PolyPhen-2 0.71
- I76N (p.Ile76Asn), cosmic curated COSV72109
- I76S (p.Ile76Ser), NCI-TCGA Cosmic COSV7210, NCI-TCGA Cosmic COSV7211, cosmic curated COSV72110, Variant assessed as somatic; moderate impact.
- P77L (p.Pro77Leu), cosmic curated COSV72110, Uncertain significance, Inborn genetic diseases
- P77S (p.Pro77Ser), NCI-TCGA Cosmic COSV7211, cosmic curated COSV72110, Variant assessed as somatic; moderate impact.
- A78P (p.Ala78Pro), Ensembl rs1732348982
- A78S (p.Ala78Ser), Ensembl rs1732348982, CADD 17.90, PolyPhen-2 0.00
- A78T (p.Ala78Thr), Ensembl rs1732348982, CADD 20.10, PolyPhen-2 0.01
- A78V (p.Ala78Val), gnomAD rs1234201261, CADD 20.90, PolyPhen-2 0.03
- E79* (p.Glu79Ter), cosmic curated COSV10152
- E79G (p.Glu79Gly), ExAC rs767236017, gnomAD rs767236017, CADD 23.60, PolyPhen-2 0.43
- E79K (p.Glu79Lys), cosmic curated COSV72110, Uncertain significance, not provided
- E81G (p.Glu81Gly), TOPMed rs1732347296, CADD 28.70, PolyPhen-2 1.00, Uncertain significance, not provided
- L82P (p.Leu82Pro), cosmic curated COSV72109
- R83* (p.Arg83Ter), NCI-TCGA Cosmic COSV7211, cosmic curated COSV72110, Variant assessed as somatic; high impact.
- R83G (p.Arg83Gly), NCI-TCGA Cosmic COSV7211, cosmic curated COSV72110, Uncertain significance, Inborn genetic diseases
- R83Q (p.Arg83Gln), ExAC rs773873557, TOPMed rs773873557, gnomAD rs773873557, CADD 27.20, PolyPhen-2 0.99, Uncertain significance, Inborn genetic diseases
- E84A (p.Glu84Ala), TOPMed rs898016993, gnomAD rs898016993, CADD 27.20
- E84D (p.Glu84Asp), Ensembl rs1037149946
- E84G (p.Glu84Gly), TOPMed rs898016993, gnomAD rs898016993, CADD 25.80, PolyPhen-2 1.00
- E84K (p.Glu84Lys), Ensembl rs2108277158
- E84Q (p.Glu84Gln), NCI-TCGA Cosmic COSV1015, cosmic curated COSV10152, Variant assessed as somatic; moderate impact.
- S85P (p.Ser85Pro), cosmic curated COSV72110
- N86D (p.Asn86Asp), gnomAD rs1328151658, CADD 23.30, PolyPhen-2 0.01
- N86T (p.Asn86Thr), cosmic curated COSV10536, TOPMed rs2048123916, gnomAD rs2048123916, CADD 17.80
- M87I (p.Met87Ile), cosmic curated COSV10536
- P88L (p.Pro88Leu), NCI-TCGA Cosmic COSV7211, cosmic curated COSV72110, Variant assessed as somatic; moderate impact.
- P88S (p.Pro88Ser), rs1560202272, ClinGen CA355191705, cosmic curated COSV10826, ClinVar RCV000758179, AlphaMissense 0.13, MetaLR 0.56, Uncertain significance, Malignant peritoneal mesothelioma
- G89R (p.Gly89Arg), ExAC rs749226344, gnomAD rs749226344, CADD 25.90, PolyPhen-2 1.00
- G89V (p.Gly89Val), cosmic curated COSV10152
- G89W (p.Gly89Trp), NCI-TCGA Cosmic COSV7211, cosmic curated COSV72111, Variant assessed as somatic; moderate impact.
- A90V (p.Ala90Val), rs878869476, Ensembl rs878869476, CADD 23.40, PolyPhen-2 0.01, Variant assessed as somatic; moderate impact.
- G91* (p.Gly91Ter), cosmic curated COSV99072
- G93E (p.Gly93Glu), NCI-TCGA Cosmic COSV7211, cosmic curated COSV72110, Variant assessed as somatic; moderate impact.
- W95* (p.Trp95Ter), cosmic curated COSV10536, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- W95R (p.Trp95Arg), TOPMed rs1411196816, gnomAD rs1411196816, CADD 25.50, PolyPhen-2 1.00
- K97R (p.Lys97Arg), ExAC rs748025086, gnomAD rs748025086, CADD 22.30, PolyPhen-2 0.07, Uncertain significance, Inborn genetic diseases
- R98W (p.Arg98Trp), cosmic curated COSV10471
- K99N (p.Lys99Asn), gnomAD rs1178386733, CADD 23.00, PolyPhen-2 0.29
- E101K (p.Glu101Lys), rs758678191, NCI-TCGA Cosmic COSV7211, cosmic curated COSV72110, ExAC rs758678191, CADD 17.00, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- V102G (p.Val102Gly), Ensembl rs2108276975, CADD 15.20, PolyPhen-2 0.03
- V102I (p.Val102Ile), gnomAD rs1181791298, CADD 15.00, PolyPhen-2 0.00
- G103D (p.Gly103Asp), cosmic curated COSV10152
- E104K (p.Glu104Lys), rs865872961, NCI-TCGA Cosmic COSV7211, cosmic curated COSV72110, Ensembl rs865872961, AlphaMissense 0.57, MetaLR 0.41, Variant assessed as somatic; moderate impact.
- K105N (p.Lys105Asn), ExAC rs745897682, TOPMed rs745897682, gnomAD rs745897682, CADD 20.20, PolyPhen-2 0.11, Uncertain significance, Inborn genetic diseases
- P108H (p.Pro108His), cosmic curated COSV10152
- G111* (p.Gly111Ter), cosmic curated COSV10471
- G111A (p.Gly111Ala), TOPMed rs927897039, CADD 16.50, PolyPhen-2 0.51
- G111E (p.Gly111Glu), cosmic curated COSV10152, TOPMed rs927897039
- G111R (p.Gly111Arg), TOPMed rs1275667362, CADD 23.70, PolyPhen-2 0.94
- E112K (p.Glu112Lys), cosmic curated COSV72109, TOPMed rs1484156080
Public MECOM analysis runs
- MECOM analysis run — MECOM (1,885 variants) — completed 2026-08-19